209 related articles for article (PubMed ID: 27706226)
1. Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.
Louw-du Toit R; Perkins MS; Snoep JL; Storbeck KH; Africander D
PLoS One; 2016; 11(10):e0164170. PubMed ID: 27706226
[TBL] [Abstract][Full Text] [Related]
2. New progestagens for contraceptive use.
Sitruk-Ware R
Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
[TBL] [Abstract][Full Text] [Related]
3. An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells.
Shields-Botella J; Duc I; Duranti E; Puccio F; Bonnet P; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):111-22. PubMed ID: 14672731
[TBL] [Abstract][Full Text] [Related]
4. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
5. Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.
Skosana SB; Woodland JG; Cartwright M; Enfield K; Komane M; Louw-du Toit R; van der Spuy Z; Avenant C; Africander D; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2019 May; 189():145-153. PubMed ID: 30822501
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea.
Witjes H; Creinin MD; Sundström-Poromaa I; Martin Nguyen A; Korver T
Eur J Contracept Reprod Health Care; 2015; 20(4):296-307. PubMed ID: 25712537
[TBL] [Abstract][Full Text] [Related]
7. Progestins used in endocrine therapy and the implications for the biosynthesis and metabolism of endogenous steroid hormones.
Louw-du Toit R; Storbeck KH; Cartwright M; Cabral A; Africander D
Mol Cell Endocrinol; 2017 Feb; 441():31-45. PubMed ID: 27616670
[TBL] [Abstract][Full Text] [Related]
8. [Actions of a 19-norprogesterone derivative on mammary gland: nomegestrol acetate].
André G
J Gynecol Obstet Biol Reprod (Paris); 2005 Feb; 34(1 Pt 1):69-84. PubMed ID: 15767920
[TBL] [Abstract][Full Text] [Related]
9. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
Louw-du Toit R; Perkins MS; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2017 Sep; 491(1):140-146. PubMed ID: 28711501
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of nomegestrol acetate.
Ruan X; Seeger H; Mueck AO
Maturitas; 2012 Apr; 71(4):345-53. PubMed ID: 22364709
[TBL] [Abstract][Full Text] [Related]
11. A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor.
Louw-du Toit R; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2020 May; 526(2):466-471. PubMed ID: 32234237
[TBL] [Abstract][Full Text] [Related]
12. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
Duijkers IJ; Klipping C; Grob P; Korver T
Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):314-25. PubMed ID: 20695770
[TBL] [Abstract][Full Text] [Related]
13. Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion.
Fu XD; Giretti MS; Goglia L; Flamini MI; Sanchez AM; Baldacci C; Garibaldi S; Sitruk-Ware R; Genazzani AR; Simoncini T
BMC Cancer; 2008 Jun; 8():166. PubMed ID: 18541028
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of different progestogens: the special case of drospirenone.
Sitruk-Ware R
Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650
[TBL] [Abstract][Full Text] [Related]
15. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
[TBL] [Abstract][Full Text] [Related]
16. A high resolution LC-MS targeted method for the concomitant analysis of 11 contraceptive progestins and 4 steroids.
Laszlo CF; Paz Montoya J; Shamseddin M; De Martino F; Beguin A; Nellen R; Bruce SJ; Moniatte M; Henry H; Brisken C
J Pharm Biomed Anal; 2019 Oct; 175():112756. PubMed ID: 31387028
[TBL] [Abstract][Full Text] [Related]
17. The use of newer progestins for contraception.
Sitruk-Ware R; Nath A
Contraception; 2010 Nov; 82(5):410-7. PubMed ID: 20933114
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.
Africander D; Verhoog N; Hapgood JP
Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337
[TBL] [Abstract][Full Text] [Related]
19. Biological effects of progestins in breast cancer.
Pasqualini JR; Ebert C
Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():11-9. PubMed ID: 12227897
[TBL] [Abstract][Full Text] [Related]
20. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
